Molbio Diagnostics has partnered with UE LifeSciences to globally distribute the iBreastExam®, a portable, radiation-free, and FDA-cleared device for early breast cancer detection. Through this collaboration, Molbio will expand access to the device across India, Africa, Southeast Asia, and other developing regions via its established healthcare networks. Designed for use in primary care settings, iBreastExam enables painless, real-time breast health screening, especially in low-resource communities. The partnership reinforces Molbio’s commitment to accessible, point-of-care diagnostic solutions and women’s health innovation.